COMMUNIQUÉS West-GlobeNewswire

Collegium to Participate in Upcoming Investor Conferences
12/11/2025
STOUGHTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management will participate in the following investor conferences: Jefferies London Healthcare [...]
Essity et sa marque JOBST® font équipe avec les Raptors de Toronto pour prouver que « Les armures ne sont pas toutes faites d'acier »
12/11/2025
TORONTO, 12 nov. 2025 (GLOBE NEWSWIRE) -- Essity, chef de file mondial des solutions de compression, et sa marque JOBST® sont ravis d'annoncer un nouveau partenariat stratégique avec les Raptors de Toronto , l'équipe de [...]
Essity Brand, JOBST®, Teams Up with Toronto Raptors to Prove that “Not All Armour is Made of Steel”
12/11/2025
TORONTO, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Essity brand, JOBST®, a global leader in compression solutions, is thrilled to announce a strategic new partnership with the Toronto Raptors , Canada’s premier basketball team [...]
LB Pharmaceuticals Appoints Kaya Pai Panandiker as Chief Commercial Officer
12/11/2025
NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals, Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a clinical-stage biopharmaceutical company developing novel therapies for schizophrenia, [...]
Beacon Therapeutics to Participate in the Jefferies Global Healthcare Conference
12/11/2025
LONDON and CAMBRIDGE, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (‘Beacon Therapeutics’ or ‘the Company’), a leading clinical-stage biotechnology company with a mission to save and [...]
Picard to Attend the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum November 20, 2025, in New York City
12/11/2025
TUCSON, Ariz., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved [...]
Evaxion announce 2026 financial calendar
12/11/2025
COPENHAGEN, Denmark, November 12, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, announces its financial calendar for 2026 as [...]
Mainz Biomed Showcases Innovative Cancer Detection Solutions at MEDICA 2025
12/11/2025
BERKELEY, Calif. and MAINZ, Germany, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of [...]
Standard Dental Labs Inc.: Investor Education Series — Part 2
12/11/2025
From Workbench to Workflow: Digitizing Craftsmanship at Scale Digitizing craftsmanship—at scale. ORLANDO, Fla., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Standard Dental Labs Inc. (OTCQB: TUTH) today published Part 2 of its [...]
X9, Inc. Announces Successful Completion of First-in-Human Feasibility Study for Ultrasound-Guided, Power-Assisted Needle Insertion Device in Hemodialysis Cannulation
12/11/2025
WALLINGFORD, Conn., Nov. 12, 2025 (GLOBE NEWSWIRE) -- X9, Inc. today announced positive results from its first-in-human clinical feasibility study evaluating the X9 Ultrasound System with Power-Assisted Needle Insertion [...]
FDA Clears Magstim Magnetic Stimulation for Chronic Pain Treatment
12/11/2025
Landmark clearance opens access to non-drug, non-invasive pain relief for millions MINNEAPOLIS, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Millions of people living with chronic pain now have a clinically proven, non-invasive, [...]
Chiesi Group Enters into an Exclusive License Agreement with Aliada Therapeutics, a Wholly Owned Subsidiary of AbbVie, to Advance Blood-Brain Barrier-Crossing Platform Technology in Lysosomal Storage Disorders
12/11/2025
PARMA, Italy, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Chiesi Group today announced it has entered into an exclusive license agreement with Aliada Therapeutics, a wholly owned subsidiary of AbbVie, to advance blood-brain [...]
Radiopharm Theranostics starts enrollment of the Third Cohort of Phase 1 Dose Escalation Clinical Trial of 177Lu-RAD204
12/11/2025
Data Safety Monitoring Committee approves advancing to a higher dose of 90mCi The first two Cohorts’ patients show tumor uptake and a favourable safety profile SYDNEY, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Radiopharm [...]
Jushi Holdings Inc. Announces Grand Opening of Beyond Hello™ Little Ferry in New Jersey
12/11/2025
Company’s first dispensary in the Garden State and 8 th state where the Company operates Opened to the public on November 7, 2025 Grand opening celebration with exclusive promotions expected November 21, 2025 A Media [...]
Aprea Therapeutics Reports Third quarter 2025 Financial Results and Provides a Clinical Update
12/11/2025
APR-1051 (WEE1 kinase inhibitor): In ongoing Phase 1 ACESOT-1051dose-escalation trial, 3 out of 4 patients at Dose Level 6 (100 mg once daily) achieved stable disease, per RECIST v1.1, in heavily pretreated [...]
Solana Company Announces Intent to Tokenize HSDT Shares on Superstate’s Opening Bell
12/11/2025
NEWTOWN, Pa., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed company that has expanded its business to include a digital asset treasury dedicated to [...]
Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
12/11/2025
NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection [...]
Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO® to Australia and New Zealand
12/11/2025
TORONTO, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, [...]
IO Biotech Announces Participation in Upcoming Investor Conferences
12/11/2025
NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced that [...]

Pages